Menu
Not yet recruiting NCT07427914

Effectiveness and Safety of Benemix® in Constipation

No phase Interventional Constipation - Functional

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Benemix®, a functional food composed of turmeric, onion, magnesium, and lactose-free, skimmed milk powder.
Who it may be relevant to
Registry conditions: Constipation - Functional. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of the Effectiveness and Safety of Benemix®, a Functional Food, in the Management of Constipation in Adults

Overview

The goal of this clinical trial is to find out whether the functional food Benemix® helps treat constipation in adults and whether it is safe to use. The main questions this study aims to answer are: Does Benemix® help improve bowel movement frequency and consistency in adults with constipation? What medical problems, if any, do participants experience while taking Benemix®? Adults with constipation will take Benemix® every day for 15 days. During the second week, participants will have either an in-person clinic visit or a telemedicine appointment for checkups and tests. Participants will also receive follow-up phone calls to record: * daily treatment adherence * signs and symptoms * the number of bowel movements each day.

Interventions

  • Dietary supplement Benemix®, a functional food composed of turmeric, onion, magnesium, and lactose-free, skimmed milk powder
    Benemix® is a functional food formulation designed to support intestinal health and relieve functional constipation in adults. It contains a combination of turmeric (Curcuma longa), onion (Allium cepa), magnesium, and lactose-free skimmed milk powder. Participants will consume one oral serving of Benemix® once daily for 15 consecutive days. The product is provided as a powdered formulation that must be reconstituted in water or milk prior to consumption. Benemix® differs from other dietary int

Primary outcome measures

  • Change in frequency of bowel movements [Time frame: From baseline (Day 0) to Day 15.]
  • Change in stool consistency measured by the Bristol Stool Form Scale (BSFS) [Time frame: From baseline (Day 0) to Day 15.]
  • Incidence of adverse events [Time frame: Throughout the 15-day intervention period.]

Eligibility criteria

Inclusion criteria

  • Adults (≥18 years old) who use Benemix® for the management of constipation.
  • Participants who are using the product for the first time.

Exclusion criteria

  • Pregnant or breastfeeding women.
  • Individuals with a diagnosis of severe gastrointestinal diseases, mental disorders, hemophilia, and/or cancer.
  • Individuals who have used laxatives within the last 7 days.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07427914 · Acta Nº 285 CEI-FE (UDEA)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗